Sign in to view content

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study

David S. Boyer, MD

Video
Published 2021

Related

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 25: RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD with Dr. Mark Gillies
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019

Category: AMD-Non-neovascular

See more